Arrhythmogenic right ventricular dysplasia screening: Difference between revisions

Jump to navigation Jump to search
m (Bot: Adding CME Category::Cardiology)
No edit summary
Line 6: Line 6:
Once [[hypertrophic cardiomyopathy]] is excluded,  arrhythmogenic right ventricular dysplasia is a common cause of [[sudden cardiac death]] among competitive athletes.
Once [[hypertrophic cardiomyopathy]] is excluded,  arrhythmogenic right ventricular dysplasia is a common cause of [[sudden cardiac death]] among competitive athletes.


==Family Screening==
==Screening==
'''Family screening'''
 
All first degree family members of the affected individual should be screened for ARVD.  This is used to establish the pattern of inheritance.  Screening should begin during the teenage years unless otherwise indicated.  Screening tests include:
All first degree family members of the affected individual should be screened for ARVD.  This is used to establish the pattern of inheritance.  Screening should begin during the teenage years unless otherwise indicated.  Screening tests include:
*Echocardiogram
*Echocardiogram
*EKG
*EKG

Revision as of 17:47, 6 May 2020

Arrhythmogenic right ventricular dysplasia Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Arrhythmogenic right ventricular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X - Ray

ECG

Cardiac MRI

Echocardiogram

Other Imaging Findings

Endomyocardial biopsy

Atuopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Arrhythmogenic right ventricular dysplasia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Arrhythmogenic right ventricular dysplasia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Arrhythmogenic right ventricular dysplasia screening

CDC on Arrhythmogenic right ventricular dysplasia screening

Arrhythmogenic right ventricular dysplasia screening in the news

Blogs onArrhythmogenic right ventricular dysplasia screening

Directions to Hospitals Treating Arrhythmogenic right ventricular dysplasia

Risk calculators and risk factors for Arrhythmogenic right ventricular dysplasia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Once hypertrophic cardiomyopathy is excluded, arrhythmogenic right ventricular dysplasia is a common cause of sudden cardiac death among competitive athletes.

Screening

Family screening

All first degree family members of the affected individual should be screened for ARVD. This is used to establish the pattern of inheritance. Screening should begin during the teenage years unless otherwise indicated. Screening tests include:

  • Echocardiogram
  • EKG
  • Signal averaged EKG
  • Holter monitoring
  • Cardiac MRI
  • Exercise stress test

References

Template:WH Template:WS CME Category::Cardiology